Skip to main content
Clinical Trials/NL-OMON25799
NL-OMON25799CompletedNot Applicable

Cross-sectional surveillance study on pneumococcal serotypes and other pathogens in nasopharyngeal samples from children and parents performed in the tenth year after introduction of pneumococcal vaccination in The Netherlands

ational Institute for Public Health and the Environment0 sites990 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
990

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • The children have to be of normal health (same health criteria apply as used in well-baby clinics when a child receives a vaccination, e.g. also children with small increases in temperature or cold are seen as children with normal health, fever >38.5°C in the last two days is not considered as normal health)
  • The parents have to be willing and able to participate in the trial according to procedure

Exclusion Criteria

  • Previous vaccinations with PCV using a vaccine and schedule that differs from the Dutch NIP of that age group
  • Medical conditions that will severely affect immunological responses to vaccinations or NP carriage rates (certain chromosomal abnormalities or craniofacial abnormalities (like Trisomy 21 or schisis), known or suspected immunodeficiency disease or other medical conditions)

Investigators

Sponsor
ational Institute for Public Health and the Environment

Similar Trials

asopharyngeal colonization in children and... | Clinical Trial